Stay updated on Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Added a Locations section listing Florida, New Jersey, New York, and Pennsylvania. Removed the state-specific location sections and the HHS Vulnerability Disclosure, and updated the page revision to v3.3.3.
    Difference
    0.5%
    Check dated 2025-12-24T15:41:10.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.2; this change appears to be a minor technical update with no alteration to the study details or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T14:48:05.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The government funding/status notice has been removed from the page. Core study details, eligibility criteria, and contact/location information remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-18T07:29:19.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Core study details such as interventions, eligibility criteria, primary outcome measures, enrollment, and locations appear unchanged between the screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-27T21:11:52.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    2%
    Check dated 2025-10-06T08:58:24.000Z thumbnail image
  9. Check
    94 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.
    Difference
    0.1%
    Check dated 2025-09-29T07:32:52.000Z thumbnail image

Stay in the know with updates to Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial page.